126 related articles for article (PubMed ID: 15173007)
1. Proteasome-mediated destruction of the cyclin a/cyclin-dependent kinase 2 complex suppresses tumor cell growth in vitro and in vivo.
Chen W; Lee J; Cho SY; Fine HA
Cancer Res; 2004 Jun; 64(11):3949-57. PubMed ID: 15173007
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
4. Modulation of beta-catenin phosphorylation/degradation by cyclin-dependent kinase 2.
Park CS; Kim SI; Lee MS; Youn CY; Kim DJ; Jho EH; Song WK
J Biol Chem; 2004 May; 279(19):19592-9. PubMed ID: 14985333
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
[TBL] [Abstract][Full Text] [Related]
6. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.
Clurman BE; Sheaff RJ; Thress K; Groudine M; Roberts JM
Genes Dev; 1996 Aug; 10(16):1979-90. PubMed ID: 8769642
[TBL] [Abstract][Full Text] [Related]
7. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
8. Hyposmotic stress induces cell growth arrest via proteasome activation and cyclin/cyclin-dependent kinase degradation.
Tao GZ; Rott LS; Lowe AW; Omary MB
J Biol Chem; 2002 May; 277(22):19295-303. PubMed ID: 11897780
[TBL] [Abstract][Full Text] [Related]
9. Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation.
Gondeau C; Gerbal-Chaloin S; Bello P; Aldrian-Herrada G; Morris MC; Divita G
J Biol Chem; 2005 Apr; 280(14):13793-800. PubMed ID: 15649889
[TBL] [Abstract][Full Text] [Related]
10. Role of proteasomes in T cell activation and proliferation.
Wang X; Luo H; Chen H; Duguid W; Wu J
J Immunol; 1998 Jan; 160(2):788-801. PubMed ID: 9551914
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
[TBL] [Abstract][Full Text] [Related]
12. Tampering with cell division by using small-molecule inhibitors of CDK-CKS protein interactions.
Hamdi A; Lesnard A; Suzanne P; Robert T; Miteva MA; Pellerano M; Didier B; Ficko-Blean E; Lobstein A; Hibert M; Rault S; Morris MC; Colas P
Chembiochem; 2015 Feb; 16(3):432-9. PubMed ID: 25619419
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta induced G(1) cell cycle arrest requires the activity of the proteasome pathway. Transforming growth factor.
Zhang F; Mönkkönen M; Roth S; Laiho M
Exp Cell Res; 2002 Dec; 281(2):190-6. PubMed ID: 12460649
[TBL] [Abstract][Full Text] [Related]
14. 3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimization.
Pevarello P; Brasca MG; Orsini P; Traquandi G; Longo A; Nesi M; Orzi F; Piutti C; Sansonna P; Varasi M; Cameron A; Vulpetti A; Roletto F; Alzani R; Ciomei M; Albanese C; Pastori W; Marsiglio A; Pesenti E; Fiorentini F; Bischoff JR; Mercurio C
J Med Chem; 2005 Apr; 48(8):2944-56. PubMed ID: 15828833
[TBL] [Abstract][Full Text] [Related]
15. Cdk2-dependent Inhibition of p21 stability via a C-terminal cyclin-binding motif.
Zhu H; Nie L; Maki CG
J Biol Chem; 2005 Aug; 280(32):29282-8. PubMed ID: 15964852
[TBL] [Abstract][Full Text] [Related]
16. Identification of interaction partners and substrates of the cyclin A1-CDK2 complex.
Diederichs S; Bäumer N; Ji P; Metzelder SK; Idos GE; Cauvet T; Wang W; Möller M; Pierschalski S; Gromoll J; Schrader MG; Koeffler HP; Berdel WE; Serve H; Müller-Tidow C
J Biol Chem; 2004 Aug; 279(32):33727-41. PubMed ID: 15159402
[TBL] [Abstract][Full Text] [Related]
17. 3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding.
Pevarello P; Brasca MG; Amici R; Orsini P; Traquandi G; Corti L; Piutti C; Sansonna P; Villa M; Pierce BS; Pulici M; Giordano P; Martina K; Fritzen EL; Nugent RA; Casale E; Cameron A; Ciomei M; Roletto F; Isacchi A; Fogliatto G; Pesenti E; Pastori W; Marsiglio A; Leach KL; Clare PM; Fiorentini F; Varasi M; Vulpetti A; Warpehoski MA
J Med Chem; 2004 Jun; 47(13):3367-80. PubMed ID: 15189033
[TBL] [Abstract][Full Text] [Related]
18. Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2.
Yam CH; Siu WY; Lau A; Poon RY
J Biol Chem; 2000 Feb; 275(5):3158-67. PubMed ID: 10652300
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition.
Rideout HJ; Wang Q; Park DS; Stefanis L
J Neurosci; 2003 Feb; 23(4):1237-45. PubMed ID: 12598612
[TBL] [Abstract][Full Text] [Related]
20. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
